Viemed Healthcare Inc. (VMD)
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA 
Viemed Healthcare, Inc. (VMD) Q3 2024 Earnings Call Transcript
Viemed Healthcare, Inc. (NASDAQ:VMD ) Q3 2024 Results Conference Call November 7, 2024 12:00 PM ET Company Participants Todd Zehnder - Chief Operating Officer Casey Hoyt - Chief Executive Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Doug Cooper - Beacon Securities Ilya Zubkov - Freedom Broker Operator Greetings, and welcome to Viemed's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Viemed Healthcare: Turning Bullish Once More On Growing Ventilator Patient Numbers
Upgraded Viemed Healthcare to 'Buy' due to bullish technicals, strong Q2 earnings, and promising growth trends in ventilator and sleep businesses. Bullish MACD crossover and strong buying volume signal potential for sustained share price increase. Q2 revenue hit $55 million, with notable organic growth and successful sales force restructuring driving performance.
